HCPCS Code J8540: Dexamethasone, Oral, 0.25 mg

HCPCS Code J8540: Dexamethasone, Oral, 0.25 mg

Bill HCPCS code J8540 for oral dexamethasone in 0.25 mg units. Learn documentation requirements, billing rules, and coding tips for compliant claim submission.

Use Code
## **What is Dexamethasone?** HCPCS code J8540 is defined as “Dexamethasone, oral, 0.25 mg.” This code is used to report the administration of oral medication to patients, typically in an outpatient or physician’s office setting. Dexamethasone is a corticosteroid widely used by healthcare professionals for its anti-inflammatory and immunosuppressive properties in conditions such as asthma exacerbations, severe allergic reactions, rheumatologic disorders, and certain types of cancer. It is also an essential part of antiemetic regimens given alongside chemotherapy drugs to help control nausea and vomiting. J8540 is billed per 0.25 mg unit, so the total number of units reported on the claim must match the exact milligram dose administered or dispensed to the patient. Proper coding ensures accurate reimbursement and is considered a reasonable step to document the use of dexamethasone as part of a patient’s treatment plan.
## **Documentation requirements for HCPCS code J8540** Medical records must include the following elements to support medical necessity and proper claim submission: - Clearly document the patient’s diagnosis and treatment plan, explaining why oral dexamethasone is appropriate (e.g., cancer-related symptoms, chemotherapy-induced nausea, inflammatory conditions, asthma exacerbation). - Maintain a signed and dated order from the prescribing provider specifying drug name, dosage, route (oral), frequency, and duration of therapy. - Ensure the claim includes the ICD-10 code corresponding to the patient’s condition or cancer being treated. - Record the drug name, strength (0.25 mg), form (oral tablet or solution), and lot number if required by payer. - Document the total milligrams administered or dispensed and convert this to billed units (1 unit per 0.25 mg). - Include date, time, and route of administration, as well as whether it was given in-office or dispensed for home use. - Briefly explain why dexamethasone was chosen and include any tapering schedule, monitoring, or follow-up instructions.
## **Billing requirements of HCPCS code J8540** Accurate billing for J8540 ensures proper payment and compliance with payer requirements: - Bill one unit for each 0.25 mg of oral dexamethasone provided. For example, a 2 mg dose would be billed as eight units. - Report the National Drug Code (NDC) if required by the payer for drug identification and pricing. - Use CMS-1500 for professional claims or UB-04 for facility claims, ensuring the date of service and place of service match the medical record. - Charges should reflect actual cost, including any pharmacy handling or compounding fees if applicable. - When billed together with other oral antiemetic drugs (e.g., Akynzeo or aprepitant), include them on the same claim and provide supporting documentation in the medical record.
## **Applicable modifiers for HCPCS code J8450** Use the following modifiers and billing practices to ensure proper claim submission: - **KX**: Append the KX modifier when dexamethasone (J8540) is administered with an approved anticancer chemotherapeutic agent to confirm that medical necessity criteria are met. - **GA or GZ**: Use when dexamethasone is not given with a covered chemotherapeutic agent. A signed Advance Beneficiary Notice (ABN) must be on file to document that the patient was informed of potential non-coverage.
## **Other relevant codes** - **J0185**: Injection, aprepitant, 1 mg - **J1453**: Injection, fosaprepitant, 1 mg - **J8650**: Nabilone, oral, 1 mg - **J2469**: Injection, palonosetron HCl, 25 mcg

Frequently asked questions

No. J1100 denotes injected dexamethasone and is inappropriate for oral administration. J8540 should be used when the drug is administered orally; note that payer policies may vary, and some may not cover orally administered dexamethasone outside chemotherapy contexts.

Claims will likely be denied as non-covered unless accompanied by the correct modifier (GA/GZ) and documentation (e.g., ABN for GA). J8540 alone, outside a covered oncology antiemetic context, often falls outside coverage.

Unit billing corresponds to 0.25 mg per unit. The quantity should reflect actual dosage dispensed and align with coverage limits (typically up to 48 hours of therapy). For example, a total dose of 10 mg equals 40 units; exceeding 48 hours of coverage may result in denial.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments